Contributor Cindy H. Dubin interviewed leading players in the prefilled syringe market to find out about their offerings and how they are addressing pharma’s needs for safety, ease of use, cost, and product differentiation.
ANALYTICAL TESTING – Diffusion Kinetics & Permeation Concentration of Human SC Characterization by Terahertz Scanning Reflectometry
Anis Rahman, PhD; Scott Frenchek; Brian Kilfoyle; Leena Patterkine, PhD; Aunik Rahman; and Bozena Michniak- Kohn, PhD; use terahertz reflectometry and spectrometry to investigate the permeation kinetics and concentration profile of active ingredients into the stratum corneum.
Derek G. Hennecke continues with part 2 of his 6-part series on lessons learned from other industries.
Carl Levoguer, PhD, examines how laser diffraction technology has been fashioned to powerfully support every stage of the drug development cycle.
James Burke believes companies adopting ECLM solutions to automate the contract lifecycle would be well advised to understand the business problem they are trying to solve and do the diligence to see where automation makes sense and where it doesn’t for their contracting process.
Bill Martineau, MBA, believes LVPs represent one of the highest value-added applications for pharmaceutical packaging. Nonetheless, demand for IV containers will expand at a lackluster pace due to trends promoting short hospital stays and less-invasive surgeries.
Contributor Cindy H. Dubin posed a series of questions to several CDMOs to find out how they are positioned to help Pharma navigate the waters of patent expirations, rising costs, shrinking timelines, and budget constraints.
Derek G. Hennecke begins part 1 of his 6-part series on lessons learned from other industries.
Eric Resnick explains how engaging packaging manufacturers early in the process helps to ensure compliance and patient safety and enhance the overall patient experience.
Contributor Cindy H. Dubin recently spoke with some of the leading companies that offer analytical instrument equipment and services to find out how they are addressing pharma’s needs for faster (and more cost-efficient) testing.
EXCLUSIVE ONLINE CONTENT
When it comes to the production of high-quality pharmaceuticals, excellence is the name of the game – in all production areas. It is the overarching goal of a well-defined course of action for….
During this educational event, scientific experts will discuss several newer applications of ICP-MS in the pharmaceutical industry that capitalize on the technique’s versatility beyond the scope of elemental impurities.
Vectura Group plc recently announced it has signed a global outlicense and development agreement with Kinaset Therapeutics Inc. for the development and commercialization of….
BD (Becton, Dickinson and Company), a leading global medical technology company, recently announced plans to invest approximately $1.2 billion over a 4-year period to expand and upgrade manufacturing capacity….
Lonza recently announced a significant investment to expand its particle engineering and drug product capabilities to meet increased market demand at its Bend, OR, site…..